
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) 52 Week Low Streak: Eighth Consecutive Session Near 52-Week Low
Updated: 15 Oct 2026 • 9:47 am
Posted by:
Sanofi Consumer Healthcare India Ltd. has now traded within 2% of its 52-week low for its eighth consecutive session, and the stock has declined 4.58% across that stretch. At 15 October 2026 at 9:22 AM IST, the share was trading at Rs 3,576.65 after touching a low of Rs 3,559.65 in the current session. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.
The stock had last traded above the current level at Rs 3,621.15 in the previous session, while today it opened at Rs 3,565.2 and touched a high of Rs 3,581.25. The market capitalisation stood at Rs 8,339.73 crore. For readers tracking Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, the key point is not just one weak print, but a sustained pattern that keeps the share price near its yearly low across multiple sessions rather than a single-day move.
Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,576.65 |
| Previous Close | Rs 3,621.15 |
| Today's Move | Rs -44.5 (-1.23%) |
| Open | Rs 3,565.2 |
| High | Rs 3,581.25 |
| Low | Rs 3,559.65 |
| Market Capitalisation | Rs 8,339.73 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) traded at Rs 3,576.65 versus the previous close of Rs 3,621.15, a fall of 1.23%. The stock opened at Rs 3,565.2, reached a high of Rs 3,581.25, touched a low of Rs 3,559.65.
Sanofi Consumer Healthcare India Ltd. share price today was lower than the previous close by Rs 44.5, or 1.23%, with the stock last traded at Rs 3,576.65. The day’s range has remained tight so far, with the stock opening at Rs 3,565.2, touching a high of Rs 3,581.25 and a low of Rs 3,559.65. That places the current price near the lower end of the intraday band, which keeps the stock under pressure around its 52-week floor.
The repeated proximity to the yearly low is what matters most in this Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak. The stock has not only stayed weak in the current market session, but it has done so after eight straight sessions of trading within 2% of the one-year trough. The current market capitalisation of Rs 8,339.73 crore also frames the scale of the company while the share price remains close to the lower boundary of its recent range.
For those following Sanofi Consumer Healthcare India Ltd. Share Price and broader Sanofi Consumer Healthcare India Ltd. Stock News, the present setup shows a stock that is still hovering near the yearly low rather than stabilising away from it. The previous session’s Rs 3,621.15 level now acts as the immediate reference point for this decline story.
What the Repeated 52-Week Lows Show
The repeated-low pattern shows that Sanofi Consumer Healthcare India Ltd. has not yet moved away from its weaker zone for eight sessions in a row. Across this Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, the cumulative move has been a decline of 4.58%, which is more useful than looking at a single day in isolation. That cumulative figure captures the persistence of the move better than one intraday print or one session’s percentage change.
This is also important because the current pattern is not just about today’s price change. The share has remained close to its 52-week low through the whole stretch, which suggests that the low end of the recent range is still acting as the main reference area for market participants. Latest Univest data confirms the repeated approach to that level, but it does not identify a specific company event, earnings trigger or other direct reason for the continued weakness.
Readers searching for Sanofi Consumer Healthcare India Ltd. New One Year Low or Sanofi Consumer Healthcare India Ltd. Back To Back 52 Week Lows should note the distinction between a stock trading near a low and a stock making a fresh record low. This article only covers the near-52-week-low pattern that has persisted across eight sessions.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,339.73 crore |
| P/E Ratio | 31.35x |
| P/B Ratio | 23.97x |
| ROE | 73.2% |
| ROCE | 98.11% |
| EPS | Rs 115.5 |
| Book Value Per Share | Rs 151.07 |
| Dividend Yield | 2.07% |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) fundamental metrics show P/E 31.35x, P/B 23.97x, ROE 73.2%, ROCE 98.11%. These figures provide context only and are not a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. has a market capitalisation of Rs 8,339.73 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.35x, P/B at 23.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 73.2% and ROCE of 98.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 115.5, book value per share of Rs 151.07, dividend yield of 2.07%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.46x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.35x |
| Benchmark Median P/E | 27.46x |
| Benchmark Average P/E | 39.89x |
| Benchmark P/E Range | 0x to 654.72x |
| Company P/B Ratio | 23.97x |
| Benchmark Median P/B | 2.8x |
| Company ROE | 73.2% |
| Benchmark Median ROE | 11.48% |
| Company ROCE | 98.11% |
| Benchmark Median ROCE | 13.28% |
| Company Market Capitalisation | Rs 8,339.73 crore |
| Benchmark Median Market Cap | Rs 808.34 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 31.35x, which is above the benchmark median of 27.46x, a difference of +14.17%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROE of 73.2%, which is above the benchmark median of 11.48%, a difference of +537.63%. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROCE of 98.11%, which is above the benchmark median of 13.28%, a difference of +638.78%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Suven Life Sciences Ltd. | SUVEN | 8,021.95 | 0 | 14.39 | -101.8 | -78.71 |
| Aarti Pharmalabs Ltd. | AARTIPHARM | 8,019.72 | 36.86 | 3.59 | 8.5 | 10.77 |
| Procter & Gamble Health Ltd. | PGHL | 8,715.26 | 24.42 | 14.16 | 62.18 | 84.86 |
| SYMBIOTEC PHARMALAB LTD | SYMBIOTEC | 7,538.21 | 73.18 | 5.36 | 11.22 | 12.41 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,136.37 | 51.62 | 5.7 | 12.11 | 17.4 |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 31.35x compared with the displayed peer median of 36.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 73.2% compares with a peer median of 11.22% across the companies shown in the table. ROCE stood at 98.11% versus the displayed peer median of 12.41%, providing a capital-efficiency comparison. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a market capitalisation of Rs 8,339.73 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching
- The stock has traded within 2% of its 52-week low for an eighth consecutive session, which keeps the weakness visible in daily market tracking.
- The cumulative decline across the streak is 4.58%, which is more informative than a one-day move for understanding the pattern.
- Valuation remains elevated relative to the industry median, especially on the P/B ratio, even as the share price stays near the yearly low.
- The company’s return ratios are strong, so the gap between operating quality and price behaviour is still wide.
- No company-specific cause is established by the latest data, so investors will likely watch price behaviour and company updates together.
About the Company
Sanofi Consumer Healthcare India Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The stock trades on the NSE and BSE under the symbol SANOFICONR. The company’s reported market capitalisation is Rs 8,339.73 crore, placing it in a mid-sized market presence within its peer universe, based on the Univest benchmark data.
The available financial snapshot highlights strong profitability ratios, with ROE at 73.2 and ROCE at 98.11, alongside EPS of Rs 115.5 and book value of Rs 151.07. Those numbers provide a useful backdrop for the ongoing Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, because they show that the price weakness is unfolding against a company with high reported return metrics and a premium valuation profile.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Sanofi Consumer Healthcare India Ltd. still near its 52-week low?
Ans. The latest Univest data shows the stock has stayed within 2% of its one-year low for eight straight sessions. The data confirms the pattern, but it does not establish a company-specific reason for the continued weakness.
What did Sanofi Consumer Healthcare India Ltd. trade at today?
Ans. The stock was trading at Rs 3,576.65 at 15 October 2026 at 9:22 AM IST. It opened at Rs 3,565.2 and touched a low of Rs 3,559.65 in the current session.
How does today’s price compare with the previous session?
Ans. The share price was down Rs 44.5, or 1.23%, versus the previous session’s Rs 3,621.15. That keeps the stock under pressure near the lower end of its current range. Comparable listed companies include Suven Life Sciences Ltd., Aarti Pharmalabs Ltd..
Is Sanofi Consumer Healthcare India Ltd. cheap compared with peers?
Ans. Not on the supplied valuation metrics. Its P/E of 31.35 and P/B of 23.97 are both above the healthcare industry medians in the benchmark data, even though its profitability ratios are strong.
What should investors monitor next in this Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak?
Ans. Investors may watch whether the stock remains near the yearly low, whether the price moves away from the current range, and whether any company update helps explain the repeated weakness. The current data does not confirm a specific trigger.
Does the current pattern mean a fresh 52-week low was made today?
Ans. No. The stock is trading within 2% of its 52-week low, which means it is near that level, but the supplied information does not say that a new low was set today.
Track Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Share Price on Univest
Use Sanofi Consumer Healthcare India Ltd. (SANOFICONR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





